• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CUV
Click for more information
0.00% $15.26

CLINUVEL PHARMACEUTICALS LIMITED

Market Cap $764.0M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Clinuvel Pharmaceuticals Limited is a global specialty pharmaceutical company. The... Clinuvel Pharmaceuticals Limited is a global specialty pharmaceutical company. The Company is focused on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening, acute disorders, as well as healthcare solutions for specialized populations. The Company is engaged in managing and expanding commercial distribution of its lead drug candidate, SCENESSE, in Europe, the United States, Israel, and Australia for the treatment of a rare, genetic metabolic disorder, erythropoietic protoporphyria (EPP). The Company’s pipeline includes PRENUMBRA, NEURACTHEL, CUV9900, and Parvysmelanotide (VLRX001). PRENUMBRA is a liquid (non-solid) injectable formulation of afamelanotide designed to provide a flexible dose of afamelanotide, a synthetic analogue of natural a-melanocyte stimulating hormone. NEURACTHEL is a novel formulation of the melanocortin adrenocorticotropic hormone (ACTH), for neurological, endocrinological and degenerative disorders.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CUV
Ann: Update - Notification of buy-back - CUV 		11:23 1 211
11:23 Last post  TheAnalyst007 Comments Created with Sketch.  1  Views Created with Sketch.  211 
CUV
CUV9900 - The sleeping giant is waking up!! 		09/05/24 12 8.8K
09/05/24 Last post  trent3727 Comments Created with Sketch.  12  Views Created with Sketch.  8.8K 
CUV
Ann: Update - Notification of buy-back - CUV 		09/05/24 2 547
09/05/24 Last post  sydneybhai Comments Created with Sketch.  2  Views Created with Sketch.  547 
CUV
Ann: Update - Notification of buy-back - CUV 		06/05/24 6 2.1K
06/05/24 Last post  trent3727 Comments Created with Sketch.  6  Views Created with Sketch.  2.1K 
CUV
Disc Medicine - Best comparison stock to Clinuvel
2
04/05/24 103 39K
04/05/24 Last post  J_Bee Comments Created with Sketch.  103  Views Created with Sketch.  39K 
CUV
Ann: Update - Notification of buy-back - CUV 		03/05/24 1 564
03/05/24 Last post  Steveenforce Comments Created with Sketch.  1  Views Created with Sketch.  564 
CUV
Ann: Syd Capital Markets Briefing Presentation 		02/05/24 12 4.5K
02/05/24 Last post  Melon felon! Comments Created with Sketch.  12  Views Created with Sketch.  4.5K 
CUV
Ann: SCENESSE European Orphan Drug Designation for XP 		29/04/24 11 4.1K
29/04/24 Last post  TheAnalyst007 Comments Created with Sketch.  11  Views Created with Sketch.  4.1K 

See All Discussions arrow Created with Sketch.

Timeline

Update - Notification of buy-back - CUV
10 May 09:08
 
Update - Notification of buy-back - CUV
09 May 09:13
 
Update - Notification of buy-back - CUV
06 May 09:18
 
Update - Notification of buy-back - CUV
03 May 09:01
 
Syd Capital Markets Briefing Presentation
01 May 09:18
 
SCENESSE European Orphan Drug Designation for XP
29 Apr 09:24
 
View More arrow Created with Sketch.

Featured News

AWJ Auric sends off first gold to Perth Mint of 2024
right-arrow Created with Sketch.
SBM AI helps lead the way for St Barbara to new FY25-27 production targets
right-arrow Created with Sketch.
PMT Patriot sniffs pegmatite grades of 3.58% among the snows of Quebec
right-arrow Created with Sketch.
ADX 4DMedical partners with West Los Angeles VA Medical Center for Veteran lung imaging study
right-arrow Created with Sketch.
WSR Westar uncovers historic ore in WA's Murchison grading 40g/t
right-arrow Created with Sketch.
AL3 AML3D to investigate copper-nickel alloy printing for US Defence
right-arrow Created with Sketch.
(20min delay)
Last
$15.26 		Change
0.350(0.00%) 		Mkt cap ! $764.0M
Open High Low Value Volume
$14.92 $15.27 $14.92 $0 14.44K
Last
$15.25 		  Change
0.350 ( 2.22 %)
Open High Low Volume
$14.98 $15.26 $14.98 2149
Last updated 11.21am 10/05/2024 ?
CUV (ASX) Chart

Top Stories

Raiden opens door to private Mallina in win-win Arrow Gold divestment

Raiden Resources has announced its execution of a farm-in deal on-site Raiden's non-core asset, the Arrow gold project.
Prominence impresses the market with uranium grading 5,269ppm in Kazakhstan Prominence Energy has seen shares rise 33% on news of uranium grading up to 5,269ppm from early sampling work in Kazakhstan.
CBA profits fall 3% in March quarter but funding portfolio is flourishing Commonwealth Bank has reported a 3 percent fall in profits for the March quarter of 2024, compared to the previous quarter.
UNITH's digital humans expand into Amazon; Facebook AI-powered 'Digital Human' chatbot developer UNITH has announced its in-house tech can now harmonise with that used by Facebook and Amazon.
Recce breathes better on positive lung infection drug pilot test results Recce Pharmaceuticals Ltd has revealed positive results from its pilot test on synthetic drug Recce 327, which aims to treat lung infections.

Featured News

RDN Raiden opens door to private Mallina in win-win Arrow Gold divestment
right-arrow Created with Sketch.
ADX 4DMedical partners with West Los Angeles VA Medical Center for Veteran lung imaging study
right-arrow Created with Sketch.
WSR Westar uncovers historic ore in WA's Murchison grading 40g/t
right-arrow Created with Sketch.
SBM AI helps lead the way for St Barbara to new FY25-27 production targets
right-arrow Created with Sketch.
NEWS Download the latest Thematics Insights Report: What it takes to get a new drug to market in Australia
right-arrow Created with Sketch.
AL3 AML3D to investigate copper-nickel alloy printing for US Defence
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.